Gene therapy of brain cancer by drug delivery nanocapsules

An all-in-one polymeric nanocapsule system that combines blood-brain barrier (BBB) crossing and glioblastoma (GBM) dual-targeting peptide, intratumoral degradable disulfide cross-linker, and genome editing tool CRISPR-Cas9 is reported to show exquisite BBB penetration and brain tumor therapy with ne...

Full description

Saved in:
Bibliographic Details
Published inMatter Vol. 5; no. 8; pp. 2502 - 2504
Main Authors Zhou, Xue-Quan, Wang, Ran, Sun, Wen, Bonnet, Sylvestre
Format Journal Article
LanguageEnglish
Published Elsevier Inc 03.08.2022
Online AccessGet full text
ISSN2590-2385
2590-2385
DOI10.1016/j.matt.2022.06.038

Cover

Loading…
Abstract An all-in-one polymeric nanocapsule system that combines blood-brain barrier (BBB) crossing and glioblastoma (GBM) dual-targeting peptide, intratumoral degradable disulfide cross-linker, and genome editing tool CRISPR-Cas9 is reported to show exquisite BBB penetration and brain tumor therapy with negligible off-target gene editing. An all-in-one polymeric nanocapsule system that combines blood-brain barrier (BBB) crossing and glioblastoma (GBM) dual-targeting peptide, intratumoral degradable disulfide cross-linker, and genome editing tool CRISPR-Cas9 is reported to show exquisite BBB penetration and brain tumor therapy with negligible off-target gene editing.
AbstractList An all-in-one polymeric nanocapsule system that combines blood-brain barrier (BBB) crossing and glioblastoma (GBM) dual-targeting peptide, intratumoral degradable disulfide cross-linker, and genome editing tool CRISPR-Cas9 is reported to show exquisite BBB penetration and brain tumor therapy with negligible off-target gene editing. An all-in-one polymeric nanocapsule system that combines blood-brain barrier (BBB) crossing and glioblastoma (GBM) dual-targeting peptide, intratumoral degradable disulfide cross-linker, and genome editing tool CRISPR-Cas9 is reported to show exquisite BBB penetration and brain tumor therapy with negligible off-target gene editing.
Author Wang, Ran
Zhou, Xue-Quan
Sun, Wen
Bonnet, Sylvestre
Author_xml – sequence: 1
  givenname: Xue-Quan
  surname: Zhou
  fullname: Zhou, Xue-Quan
  organization: State Key Laboratory of Fine Chemicals, Dalian University of Technology, 2 Linggong Road, Dalian 116024, P.R. China
– sequence: 2
  givenname: Ran
  surname: Wang
  fullname: Wang, Ran
  organization: State Key Laboratory of Fine Chemicals, Dalian University of Technology, 2 Linggong Road, Dalian 116024, P.R. China
– sequence: 3
  givenname: Wen
  surname: Sun
  fullname: Sun, Wen
  email: sunwen@dlut.edu.cn
  organization: State Key Laboratory of Fine Chemicals, Dalian University of Technology, 2 Linggong Road, Dalian 116024, P.R. China
– sequence: 4
  givenname: Sylvestre
  surname: Bonnet
  fullname: Bonnet, Sylvestre
  email: bonnet@chem.leidenuniv.nl
  organization: Leiden Institute of Chemistry, Universiteit Leiden, Einsteinweg 55, 2333 CC Leiden, Netherlands
BookMark eNp9kM9KAzEQh4MoWGtfwFNeYNdJstk_4kWKVqHgRc8hm8xqyjZbkrSwb--WehAPPc0w_L5h5rshl37wSMgdg5wBK-83-VanlHPgPIcyB1FfkBmXDWRc1PLyT39NFjFuAKYkE1UhZuRhhR5p-sagdyMdOtoG7Tw12hsMtB2pDfsvarF3Bwwj9doPRu_ivsd4S6463Udc_NY5-Xx5_li-Zuv31dvyaZ0ZAZAyYVuNlSzqpmBgUHMJRWulbWtbiq7CrkFemkawuuNFZaWRjcAKudEap7EUc1Kf9powxBiwU8Ylndzg03Rrrxioowa1UUcN6qhBQakmDRPK_6G74LY6jOehxxOE01MHh0FF43DyYV1Ak5Qd3Dn8Bx9xeTU
CitedBy_id crossref_primary_10_1016_j_nantod_2024_102310
crossref_primary_10_3390_jcm13237449
crossref_primary_10_1002_adfm_202412040
Cites_doi 10.1016/j.ejpb.2015.03.018
10.1002/smll.202101460
10.1126/science.aba8853
10.1038/s41573-020-0090-8
10.1126/scitranslmed.3003601
10.1126/sciadv.abm8011
ContentType Journal Article
Copyright 2022 Elsevier Inc.
Copyright_xml – notice: 2022 Elsevier Inc.
DBID AAYXX
CITATION
DOI 10.1016/j.matt.2022.06.038
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
EISSN 2590-2385
EndPage 2504
ExternalDocumentID 10_1016_j_matt_2022_06_038
S2590238522003332
GroupedDBID AAEDW
AAIAV
AALRI
AAXUO
ADJPV
AFTJW
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
EBS
EJD
FDB
HX~
M3Z
M41
OK1
0R~
AAMRU
AAYWO
AAYXX
ABDGV
ABJNI
ACVFH
ADCNI
ADVLN
AEUPX
AFPUW
AGCQF
AIGII
AITUG
AKAPO
AKBMS
AKRWK
AKYEP
APXCP
CITATION
ROL
ID FETCH-LOGICAL-c300t-3dbae75489410cea2504bd5db8d63f7ef9e26c9318f247d5c593e7e2caaec9353
ISSN 2590-2385
IngestDate Tue Jul 01 03:52:37 EDT 2025
Thu Apr 24 23:04:03 EDT 2025
Thu Jul 20 20:09:33 EDT 2023
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c300t-3dbae75489410cea2504bd5db8d63f7ef9e26c9318f247d5c593e7e2caaec9353
PageCount 3
ParticipantIDs crossref_citationtrail_10_1016_j_matt_2022_06_038
crossref_primary_10_1016_j_matt_2022_06_038
elsevier_sciencedirect_doi_10_1016_j_matt_2022_06_038
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-08-03
PublicationDateYYYYMMDD 2022-08-03
PublicationDate_xml – month: 08
  year: 2022
  text: 2022-08-03
  day: 03
PublicationDecade 2020
PublicationTitle Matter
PublicationYear 2022
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Mitchell, Billingsley, Haley, Wechsler, Peppas, Langer (bib2) 2021; 20
Walton, Christie, Whittaker, Kleinstiver (bib4) 2020; 368
Yao, Sun, Huang, Dou, Lin, Chen, Ruan, Mao, Yu, Zeng (bib6) 2012; 4
Pérez-Herrero, Fernández-Medarde (bib1) 2015; 93
Zou, Sun, Yang, Zheng, Shimoni, Ruan, Wang, Zhang, Yin, Huang (bib5) 2022; 8
Li, Sun, Li, Luo, He, Sun (bib3) 2021; 17
Yao (10.1016/j.matt.2022.06.038_bib6) 2012; 4
Li (10.1016/j.matt.2022.06.038_bib3) 2021; 17
Walton (10.1016/j.matt.2022.06.038_bib4) 2020; 368
Mitchell (10.1016/j.matt.2022.06.038_bib2) 2021; 20
Zou (10.1016/j.matt.2022.06.038_bib5) 2022; 8
Pérez-Herrero (10.1016/j.matt.2022.06.038_bib1) 2015; 93
References_xml – volume: 17
  start-page: 2101460
  year: 2021
  ident: bib3
  article-title: Small-molecule prodrug nanoassemblies: an emerging nanoplatform for anticancer drug delivery
  publication-title: Small
– volume: 8
  start-page: eabm8011
  year: 2022
  ident: bib5
  article-title: Blood-brain barrier-penetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy
  publication-title: Sci. Adv.
– volume: 93
  start-page: 52
  year: 2015
  end-page: 79
  ident: bib1
  article-title: Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy
  publication-title: Eur. J. Pharm. Biopharm.
– volume: 368
  start-page: 290
  year: 2020
  end-page: 296
  ident: bib4
  article-title: Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants
  publication-title: Science
– volume: 20
  start-page: 101
  year: 2021
  end-page: 124
  ident: bib2
  article-title: Engineering precision nanoparticles for drug delivery
  publication-title: Nat. Rev. Drug Discov.
– volume: 4
  start-page: 130ra48
  year: 2012
  ident: bib6
  article-title: Targeted delivery of PLK1-siRNA by ScFv suppresses Her2
  publication-title: Sci. Transl. Med.
– volume: 93
  start-page: 52
  year: 2015
  ident: 10.1016/j.matt.2022.06.038_bib1
  article-title: Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy
  publication-title: Eur. J. Pharm. Biopharm.
  doi: 10.1016/j.ejpb.2015.03.018
– volume: 17
  start-page: 2101460
  year: 2021
  ident: 10.1016/j.matt.2022.06.038_bib3
  article-title: Small-molecule prodrug nanoassemblies: an emerging nanoplatform for anticancer drug delivery
  publication-title: Small
  doi: 10.1002/smll.202101460
– volume: 368
  start-page: 290
  year: 2020
  ident: 10.1016/j.matt.2022.06.038_bib4
  article-title: Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants
  publication-title: Science
  doi: 10.1126/science.aba8853
– volume: 20
  start-page: 101
  year: 2021
  ident: 10.1016/j.matt.2022.06.038_bib2
  article-title: Engineering precision nanoparticles for drug delivery
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/s41573-020-0090-8
– volume: 4
  start-page: 130ra48
  year: 2012
  ident: 10.1016/j.matt.2022.06.038_bib6
  article-title: Targeted delivery of PLK1-siRNA by ScFv suppresses Her2+ breast cancer growth and metastasis
  publication-title: Sci. Transl. Med.
  doi: 10.1126/scitranslmed.3003601
– volume: 8
  start-page: eabm8011
  year: 2022
  ident: 10.1016/j.matt.2022.06.038_bib5
  article-title: Blood-brain barrier-penetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy
  publication-title: Sci. Adv.
  doi: 10.1126/sciadv.abm8011
SSID ssj0002213743
Score 2.2124627
Snippet An all-in-one polymeric nanocapsule system that combines blood-brain barrier (BBB) crossing and glioblastoma (GBM) dual-targeting peptide, intratumoral...
SourceID crossref
elsevier
SourceType Enrichment Source
Index Database
Publisher
StartPage 2502
Title Gene therapy of brain cancer by drug delivery nanocapsules
URI https://dx.doi.org/10.1016/j.matt.2022.06.038
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZpcumltDShadqiQ2-Lgy1ZXju3tLSEhBaaB7vkYixp3BIWb1jsw-bXZ8aSHw2b0PRizGDLluZjNCN9M2LssymzJM4MsfsjGcQafTitNUYpZSxDa-JCAyU4__iZnFzFp3M1H2VcU3ZJrQ_N3ca8kv_RKspQr5Ql-wzN9o2iAO9Rv3hFDeP1n3RMNaMnLoOq3SjXdN4D8bgMrMivtKvm98TCgrgX60lVVDhxYVS88LzB7iCnoh5xdK__LBsa93kDwa9mwM7MLyyfD6KLpjVZsyGb7AvRZlqzfrFeUAEPT631ywoYkRINQg7WB8OiMMD53G05wwaZN59qhJJ0bApVKEbTKpVK22iy3erBzSE66MRtFaKtp-pKvvxdH_vBvNWzCTui2k1ObeTURk5sPZm-YDsCwwc02DvHZ-ezs371TYhIuuyLvk8-o8qR_x7-zGavZeSJXL5mr3wIwY8dHt6wLajesiPCAvdY4MuSt1jgDgtcrzlhgXdY4GMs7LKr798uv54E_lyMwMgwrANpdQFTDDWzOAoNFDS02iqrU5vIcgplBiIxGVrrUsRTq4zKJExBmKIAFCu5x7arZQXvGDcJVWhLs1BbjNOt0GmpMowxQQFtCUf7LOr6nRtfNJ7OLlnkjw_6Ppv079y6kilPPq264cy90-ecuRwB8sR775_1lQP2cgD5B7Zdrxr4iN5krT95aNwDavJzLg
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gene+therapy+of+brain+cancer+by+drug+delivery+nanocapsules&rft.jtitle=Matter&rft.au=Zhou%2C+Xue-Quan&rft.au=Wang%2C+Ran&rft.au=Sun%2C+Wen&rft.au=Bonnet%2C+Sylvestre&rft.date=2022-08-03&rft.issn=2590-2385&rft.eissn=2590-2385&rft.volume=5&rft.issue=8&rft.spage=2502&rft.epage=2504&rft_id=info:doi/10.1016%2Fj.matt.2022.06.038&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_matt_2022_06_038
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2590-2385&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2590-2385&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2590-2385&client=summon